Go Pro
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel
NASDAQ:AIFF

Firefly Neuroscience Q2 2025 Earnings Report

Firefly Neuroscience logo
$2.01 +0.82 (+68.91%)
Closing price 09/25/2026 04:00 PM Eastern
Extended Trading
$1.82 -0.19 (-9.20%)
As of 09/25/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Firefly Neuroscience EPS Results

Actual EPS
-$0.14
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Firefly Neuroscience Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Firefly Neuroscience Announcement Details

Quarter
Q2 2025
Date
8/13/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Firefly Neuroscience Earnings Headlines

A Drug-Free ADHD Treatment for Kids Gets a Brain-Scan Network Behind It
September 26 at 6:31 PM  |  msn.comhttps://www.msn.com/en-ca/news/other/a-drug-free-adhd-treatment-for-kids-gets-a-brain-scan-network-behind-it/ar-AA2cY9U9
Firefly Collaborates With NeuroSigma On Promoting Device For Pediatric ADHD; Stock Surges Over 25%
September 26 at 8:22 AM  |  rttnews.comhttps://www.rttnews.com/3694021/firefly-collaborates-with-neurosigma-on-promoting-device-for-pediatric-adhd-stock-surges-over-25.aspx
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
September 27 at 1:00 AM  |  Base Camp Trading (Ad)
Firefly Neuroscience, Inc. And NeuroSigma, Inc. Partner To Expand Access To First FDA-Cleared, Non-Drug Treatment For Pediatric ADHD
September 25 at 12:18 PM  |  marketscreener.comM
Firefly Hikes on Partnering with NeuroSigma
September 25 at 12:18 PM  |  baystreet.cahttps://www.baystreet.ca/techinsider/5778/Firefly-Hikes-on-Partnering-with-NeuroSigma
Firefly Neuroscience and NeuroSigma Announce Partnership to Expand Access to FDA-Cleared Monarch eTNS System for Pediatric ADHD
September 25 at 7:51 AM  |  quiverquant.comQ
See More Firefly Neuroscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Firefly Neuroscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Firefly Neuroscience and other key companies, straight to your email.

About Firefly Neuroscience

Firefly Neuroscience (NASDAQ:AIFF) is a medical technology company focused on applying artificial intelligence to brain health and neurological care. The company develops software designed to analyze electroencephalography (EEG) data and identify objective patterns associated with cognitive and mental health conditions.

Its principal offering is the Brain Network Analytics (BNA) platform, which uses machine-learning algorithms to evaluate brain activity and generate biomarkers intended to support the assessment, monitoring and management of conditions such as cognitive impairment and depression. The platform is designed to help clinicians complement conventional evaluations with data-driven insights into brain function.

Firefly Neuroscience serves healthcare providers, researchers and other organizations involved in neuroscience and mental health. The company’s technology is focused primarily on clinical and research applications, although specific geographic markets and commercial partnerships may evolve as adoption expands. Firefly Neuroscience is led by Chief Executive Officer Jon Olsen.

View Firefly Neuroscience Profile
Earnings Tools